ROYALTY PHARMA

royalty-pharma-logo

Royalty Pharma has created a rapidly growing company within the biopharmaceutical industry through the acquisition of revenue producing intellectual property – principally, royalty interests in marketed and late stage development biopharmaceutical products. Royalty Pharma does not discover, develop, manufacture or market products. Instead, the Company provides liquidity to royalty owners and assumes the future risks and rewards of ownership. Royalty Pharma has been working with research instit... utions, inventors and biotechnology & pharmaceutical companies since 1996, and now owns royalty interests in forty four approved and marketed biopharmaceutical products and seven products in clinical trials and/or under review with the United States Food and Drug Administration (“FDA”) and/or the European Medicines Agency ("EMA”).

#SimilarOrganizations #People #Financial #More

ROYALTY PHARMA

Social Links:

Industry:
Biotechnology Manufacturing Pharmaceutical

Founded:
1996-01-01

Status:
Active

Contact:
212-883-0200

Total Funding:
0

Technology used in webpage:
SPF Google Font API Microsoft Exchange Online Amazon Office 365 Mail IPv6 ReCAPTCHA Microsoft Azure DNS GoDaddy DNS Apache 2.4


Similar Organizations

welmedix-consumer-healthcare-logo

Welmedix Consumer Healthcare

Welmedix Consumer Healthcare develops and markets pharmaceutical products.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

onspira-therapeutics-logo

Onspira Therapeutics

Onspira Therapeutics operates as a clinical-stage biopharmaceutical company.


Current Advisors List

mark-a-maloney_image

Mark A. Maloney Board Member @ Royalty Pharma
Board_member

ted-w-love_image

Ted W. Love Board Member @ Royalty Pharma
Board_member
2020-08-01

Current Employees Featured

sandy-balkin_image

Sandy Balkin
Sandy Balkin SVP Strategy and Analytics @ Royalty Pharma
SVP Strategy and Analytics
2021-01-01

pablo-legoretta_image

Pablo Legoretta
Pablo Legoretta CEO & Founder @ Royalty Pharma
CEO & Founder
1996-09-01

george-lloyd_image

George Lloyd
George Lloyd Executive Vice President, Investments and General Counsel @ Royalty Pharma
Executive Vice President, Investments and General Counsel

jim-reddoch_image

Jim Reddoch
Jim Reddoch Chief Scientific Officer, Executive Vice President, Head of Research and Investments @ Royalty Pharma
Chief Scientific Officer, Executive Vice President, Head of Research and Investments
2008-07-01

Founder


pablo-legoretta_image

Pablo Legoretta

Stock Details


Company's stock symbol is NASDAQ:RPRX

Acquisitions List

Date Company Article Price
2019-11-07 Eisai Eisai acquired by Royalty Pharma 330 M USD

Investors List

general-atlantic_image

General Atlantic

General Atlantic investment in Private Equity Round - Royalty Pharma

Investments List

Date Company Article Money raised
2022-07-01 Cytokinetics Royalty Pharma investment in Post-IPO Debt - Cytokinetics 450 M USD
2022-05-18 ApiJect Royalty Pharma investment in Private Equity Round - ApiJect 111 M USD
2021-11-22 BioCryst Pharmaceuticals Royalty Pharma investment in Post-IPO Equity - BioCryst Pharmaceuticals 350 M USD
2020-12-07 BioCryst Pharmaceuticals Royalty Pharma investment in Post-IPO Debt - BioCryst Pharmaceuticals 325 M USD
2019-11-07 Epizyme Royalty Pharma investment in Post-IPO Equity - Epizyme 100 M USD

More informations about "Royalty Pharma" on Search Engine